Cannabis Production in the European Union – Spectrum Denmark Granted Production Licence Français

ODENSE, Denmark, and SMITHS FALLS, ONDec. 18, 2017 /CNW/ – Further to a December 5th press release announcing plans to establish a 40,000 mfacility in the Danish city of Odense, Spectrum Cannabis Denmark has been issued a cannabis production licence by Laegemiddelstyrelsen, Denmark’s Medicines Agency. Danish Health Minister, Ellen Trane Nørbye, announced the news today at a press conference. Spectrum Cannabis Denmark is a partnership between Danish Cannabis, one of Europe’s largest hemp producers, and Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED).

To the Company’s knowledge, this is the first federal production licence issued to a Canadian cannabis producer anywhere in the European Union, a major milestone in an emerging market. With the announcement, Denmark has joined the Netherlands as the only two European countries with federally permitted medical cannabis production.

Speaking to local media, Minister Nørbye commented, “Medical cannabis has enormous potential and my role as Minister of Health is to help secure that the new medical cannabis law becomes a success for patients and for Denmark.”

Cannabis produced at the Odense facility is forecasted to exceed the needs of the Danish market and will be exported to other federally legal jurisdictions in the European Union.

“Entering Denmark was a strategic choice for us because we sensed the country would move fast to establish federal production capabilities. Using our expertise and in collaboration with excellent local partners, Canopy is now set to become the first ACMPR participant to also produce cannabis products in the European Union,” said Bruce Linton, Chairman and CEO, Canopy Growth. “In 2014 we began with a small Canadian patient group and grew it rapidly by offering high-quality products and actively engaging with the medical community. We intend to repeat this model of success on the other side of the Atlantic and solidify our position as the global leaders in the cannabis industry.”

Canopy Growth has stabilized an industry-leading selection of cannabis genetics in its Canadian facilities and will ship a variety of Spectrum Cannabis clones to Odense to begin growth cycles as soon as spring 2018 when the greenhouse retrofit is targeted to be complete.

The licence is being issued without conditions, meaning that Spectrum Cannabis Denmark will not be limited to a production cap or limited to the product formats it can produce. High quality oils and dried cannabis flowers will be produced in Odense and sold under the Spectrum Cannabis brand using the proprietary Spectrum colour-coded strain classification system.

As in Canada, Canopy Growth will use its experience to engage the physician community in Denmark to ensure that physicians are able to access fact-based information pertaining to dosing, and prescribing to appropriate patients.

The licence announced today is valid through 2021.

Post by TraderX

Comments are closed.